PROS1 and influenza: Umifenovir (Arbidol) is a drug authorized in Russia for influenza treatment and has been described as an inhibitor of SARS-CoV-2 S protein-mediated cell–cell fusion in vitro, probably interacting with viral entry and intracellular vesicle trafficking [39].